Neuropsychological and psychiatric outcomes in encephalitis: A multi-centre case-control study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 24 05 2019
accepted: 01 03 2020
entrez: 27 3 2020
pubmed: 27 3 2020
medline: 26 6 2020
Statut: epublish

Résumé

Our aim was to compare neuropsychological and psychiatric outcomes across three encephalitis aetiological groups: Herpes simplex virus (HSV), other infections or autoimmune causes (Other), and encephalitis of unknown cause (Unknown). Patients recruited from NHS hospitals underwent neuropsychological and psychiatric assessment in the short-term (4 months post-discharge), medium-term (9-12 months after the first assessment), and long-term (>1-year). Healthy control subjects were recruited from the general population and completed the same assessments. Patients with HSV were most severely impaired on anterograde and retrograde memory tasks. In the short-term, they also showed executive, IQ, and naming deficits, which resolved in the long-term. Patients with Other or Unknown causes of encephalitis showed moderate memory impairments, but no significant impairment on executive tests. Memory impairment was associated with hippocampal/medial temporal damage on magnetic resonance imaging (MRI), and naming impairment with left temporal and left frontal abnormalities. Patients reported more subjective cognitive complaints than healthy controls, with tiredness a significant problem, and there were high rates of depression and anxiety in the HSV and the Other encephalitis groups. These subjective, self-reported complaints, depression, and anxiety persisted even after objectively measured neuropsychological performance had improved. Neuropsychological and psychiatric outcomes after encephalitis vary according to aetiology. Memory and naming are severely affected in HSV, and less so in other forms. Neuropsychological functioning improves over time, particularly in those with more severe short-term impairments, but subjective cognitive complaints, depression, and anxiety persist, and should be addressed in rehabilitation programmes.

Identifiants

pubmed: 32210460
doi: 10.1371/journal.pone.0230436
pii: PONE-D-19-14742
pmc: PMC7094865
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0230436

Subventions

Organisme : Department of Health
ID : IS-HPU-1112-10117
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-0108-10048
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-0108-10,048
Pays : United Kingdom
Organisme : Department of Health
ID : 17/63/110
Pays : United Kingdom
Organisme : Department of Health
ID : 12/205/28
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2014 Jul 29;9(7):e103496
pubmed: 25072738
J Neurol Neurosurg Psychiatry. 1996 Nov;61(5):478-84
pubmed: 8937342
Neuropsychology. 2005 Sep;19(5):555-65
pubmed: 16187874
Arch Phys Med Rehabil. 2006 May;87(5):611-8
pubmed: 16635622
J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):23-8
pubmed: 11413257
Implement Sci. 2015 Mar 20;10:37
pubmed: 25889994
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):195-8
pubmed: 21933952
J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1334-42
pubmed: 7964808
J Infect. 2012 Apr;64(4):347-73
pubmed: 22120595
Neurology. 2014 Feb 4;82(5):443-51
pubmed: 24384647
Can J Neurol Sci. 2018 Sep;45(5):540-544
pubmed: 29936915
Clin Infect Dis. 2012 Apr;54(7):899-904
pubmed: 22281844
Lancet Neurol. 2008 Dec;7(12):1091-8
pubmed: 18851928
Lancet Neurol. 2013 Feb;12(2):157-65
pubmed: 23290630
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Arch Phys Med Rehabil. 2013 Sep;94(9):1747-52
pubmed: 23529143
Neuropsychol Rehabil. 2007 Aug-Oct;17(4-5):478-505
pubmed: 17676531
J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):387-91
pubmed: 24403282
JAMA Neurol. 2017 Jan 1;74(1):50-59
pubmed: 27893017
PLoS One. 2014 Sep 05;9(9):e104169
pubmed: 25192177
Emerg Infect Dis. 2016 Mar;22(3):426-32
pubmed: 26890626
J Neurosurg. 1994 Aug;81(2):169-73
pubmed: 8027796
J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):13-22
pubmed: 11413256
Arch Neurol. 1996 Oct;53(10):972-8
pubmed: 8859058
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Brain. 2004 Mar;127(Pt 3):701-12
pubmed: 14960497
Brain. 2010 Sep;133(9):2734-48
pubmed: 20663977
PLoS One. 2017 Jan 26;12(1):e0170215
pubmed: 28125598
Epilepsy Res. 2001 Mar;43(3):227-37
pubmed: 11248534
Brain. 1981 Mar;104(Pt 1):129-48
pubmed: 6258703
J Neurol. 2017 Feb;264(2):407-415
pubmed: 27766471
Pediatr Neurol. 2000 Jan;22(1):8-18
pubmed: 10669199
Lancet Infect Dis. 2010 Dec;10(12):835-44
pubmed: 20952256
Brain Inj. 1992 Jan-Feb;6(1):65-70
pubmed: 1739854
Neuropsychiatry Neuropsychol Behav Neurol. 1997 Jul;10(3):180-9
pubmed: 9297711
Ann Neurol. 2018 Jan;83(1):166-177
pubmed: 29293273
Can J Psychiatry. 1992 May;37(4):271-3
pubmed: 1611590
PLoS One. 2016 Mar 09;11(3):e0151145
pubmed: 26960197

Auteurs

Lara Harris (L)

Institute of Psychiatry, Psychology and Neuroscience, King's College London (KCL), Camberwell, London, United Kingdom.

Julia Griem (J)

Institute of Psychiatry, Psychology and Neuroscience, King's College London (KCL), Camberwell, London, United Kingdom.

Alison Gummery (A)

National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections and Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.

Laura Marsh (L)

Institute of Psychiatry, Psychology and Neuroscience, King's College London (KCL), Camberwell, London, United Kingdom.

Sylviane Defres (S)

National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections and Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Tropical and Infectious Diseases Unit, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.

Maneesh Bhojak (M)

The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Kumar Das (K)

The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Ava Easton (A)

Encephalitis Society, Malton, United Kingdom.
Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.

Tom Solomon (T)

National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections and Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Michael Kopelman (M)

Institute of Psychiatry, Psychology and Neuroscience, King's College London (KCL), Camberwell, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH